Phase 1/2 Trial of Selinexor (KPT-330) With Docetaxel for Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT03095612 · TERMINATED
Trial details
- NCT number
- NCT03095612
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-22
- Primary completion
- 2022-11-08
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.